MY196399A - Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers - Google Patents

Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Info

Publication number
MY196399A
MY196399A MYPI2019005923A MYPI2019005923A MY196399A MY 196399 A MY196399 A MY 196399A MY PI2019005923 A MYPI2019005923 A MY PI2019005923A MY PI2019005923 A MYPI2019005923 A MY PI2019005923A MY 196399 A MY196399 A MY 196399A
Authority
MY
Malaysia
Prior art keywords
peptides
combination
present
scaffolds
cancers
Prior art date
Application number
MYPI2019005923A
Inventor
Anita Wiebe
Oliver Schoor
Jens Fritsche
Andrea Mahr
Toni Weinschenk
Harpreet Singh
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority to MYPI2019005923A priority Critical patent/MY196399A/en
Publication of MY196399A publication Critical patent/MY196399A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
MYPI2019005923A 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers MY196399A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2019005923A MY196399A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2019005923A MY196399A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Publications (1)

Publication Number Publication Date
MY196399A true MY196399A (en) 2023-03-28

Family

ID=87569458

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019005923A MY196399A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Country Status (1)

Country Link
MY (1) MY196399A (en)

Similar Documents

Publication Publication Date Title
MX2017014008A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers.
PH12018500551A1 (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018500189A1 (en) Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
PH12019501377A1 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PH12018500864A1 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
PH12017502261A1 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
EP3875467A3 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
PH12018501865B1 (en) Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
WO2018189152A3 (en) Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
PH12019502308A1 (en) Peptides and combination thereof for use in the immunotherapy against cancers
PH12018500004A1 (en) Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
PH12018502159A1 (en) Immunotheraphy against melanoma and other cancers
PH12019502300A1 (en) Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers
PH12017501994A1 (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
PH12020551958A1 (en) Peptides for use in immunotherapy against cancers
MY196837A (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018502108A1 (en) Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
PH12018500665A1 (en) Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
PH12018501639A1 (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
MY196395A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof For use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196687A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196396A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196688A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
MY196399A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY197511A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers